HERON THERAPEUTICS, INC. /DE/ Cash and Cash Equivalents
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Cash and Cash Equivalents of $20.72 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-10
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $20.72M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $26.12M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $28.65M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $43.07M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $20.72M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $26.12M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $28.65M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $43.07M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $16.52M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $19.27M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $25.80M 10-K · filed 2026-02-26 |
| 2024-09-30 | $25.74M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $18.39M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $20.45M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $28.68M 10-K · filed 2025-02-27 |
| 2023-09-30 | $34.86M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $13.46M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $27.09M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $15.36M 10-K · filed 2024-03-12 |
| 2022-09-30 | $50.44M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $48.61M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $56.91M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $90.54M 10-K · filed 2023-03-29 |
| 2021-09-30 | $159.57M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $191.17M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $59.74M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $105.14M 10-K · filed 2022-02-28 |
| 2020-09-30 | $95.14M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $80.73M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $103.28M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $71.90M 10-K · filed 2021-02-24 |
| 2019-09-30 | $60.11M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $53.04M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $23.46M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $31.84M 10-K · filed 2020-03-02 |
| 2018-09-30 | $53.93M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $258.93M 10-Q · filed 2019-08-05 |
| 2018-03-31 | $46.58M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $144.58M 10-Q · filed 2019-08-05 |
| 2017-09-30 | $65.52M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $30.28M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $83.51M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $13.41M 10-K · filed 2019-02-22 |
| 2016-09-30 | $45.64M 10-Q · filed 2017-11-06 |
| 2016-06-30 | $61.94M 10-Q · filed 2017-08-09 |
| 2016-03-31 | $68.02M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $75.18M 10-K · filed 2019-02-22 |
| 2015-09-30 | $152.99M 10-Q · filed 2016-11-08 |
| 2015-06-30 | $171.53M 10-Q · filed 2016-08-08 |
| 2015-03-31 | $55.56M 10-Q · filed 2016-05-05 |
| 2014-12-31 | $72.67M 10-K · filed 2018-02-27 |
| 2014-09-30 | $86.21M 10-Q · filed 2015-11-06 |
| 2014-06-30 | $105.01M 10-Q · filed 2015-08-07 |
| 2014-03-31 | $57.48M 10-Q · filed 2015-05-08 |
| 2013-12-31 | $72.29M 10-K · filed 2017-02-23 |
| 2013-09-30 | $22.60M 10-Q · filed 2014-11-06 |
| 2013-06-30 | $34.85M 10-Q · filed 2014-08-04 |
| 2013-03-31 | $45.72M 10-Q · filed 2014-05-12 |
| 2012-12-31 | $53.51M 10-K · filed 2016-02-19 |
| 2012-09-30 | $60.05M 10-Q · filed 2013-11-12 |
| 2012-06-30 | $12.44M 10-Q · filed 2013-08-08 |
| 2012-03-31 | $13.44M 10-Q · filed 2013-05-10 |
| 2011-12-31 | $17.97M 10-K · filed 2015-03-13 |
| 2011-09-30 | $21.02M 10-Q · filed 2012-11-05 |
| 2011-06-30 | $21.33M 10-Q · filed 2012-08-09 |
| 2011-03-31 | $1.08M 10-Q · filed 2012-05-10 |
| 2010-12-31 | $2.11M 10-K · filed 2014-03-07 |
| 2010-09-30 | $3.02M 10-Q · filed 2011-11-07 |
| 2010-06-30 | $5.74M 10-Q · filed 2011-08-08 |
| 2009-12-31 | $7.59M 10-K · filed 2013-03-01 |
| 2008-12-31 | $9.97M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |